Clinical Trials on Oligoprogressive

Total 18 results

ImmuneSensor Therapeutics Inc.

Recruiting

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies

Oligoprogressive

United States
M.D. Anderson Cancer Center

Not yet recruiting

A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

OligoProgressive Metastatic Disease

United States
University of California, Davis
National Cancer Institute (NCI)

Recruiting

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) (VALOROUS)

Sarcoma | Breast Cancer | Head and Neck Cancer | Oligoprogressive | Other Cancer

United States
The Netherlands Cancer Institute
Maarten van de Weijden Foundation

Recruiting

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study (COSMO)

Oligoprogressive | Metastatic Cancer | Breast Cancer Invasive

Netherlands
British Columbia Cancer Agency
Princess Margaret Hospital, Canada; London Regional Cancer Program, Canada; Tom...

Not yet recruiting

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Quality of Life | Toxicity Due to Radiotherapy | Oligometastatic Disease | Oligoprogression

Canada
Centre hospitalier de l'Université de Montréal...

Recruiting

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer (SUPPRESS)

Head and Neck Cancer | Oligoprogressive | Metastatic Cancer

Canada
Istituto Clinico Humanitas

Recruiting

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT (IOSCAR)

Oligorecurrent and Oligoprogressive Prostate Cancer Patients

Italy
Sunnybrook Health Sciences Centre

Recruiting

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Oligoprogressive | Castration-Resistant Prostate Cancer

Canada
University of California, Davis
National Cancer Institute (NCI)

Recruiting

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) (OBLITERATE)

Oligoprogressive | Non-small Cell Lung Cancer | Small-cell Lung Cancer

United States
Centre Francois Baclesse
Association de Neuro-Oncologues d'Expression Francaise

Active, not recruiting

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation. (OligoBM-01)

Brain Metastasis | Oligoprogression

France
Sun Yat-sen University

Recruiting

A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Oligoprogressive | Non-small Cell Lung Cancer

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

Oligoprogressive | Non Small Cell Lung Cancer
University of Texas Southwestern Medical Center

Active, not recruiting

SAbR For Oligo-Progressive Renal Cell Cancer.

Oligoprogressive Renal Cell Carcinoma

United States
AIO-Studien-gGmbH
AstraZeneca

Recruiting

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE)

NSCLC | EGFR Positive Non-small Cell Lung Cancer | Oligoprogression

Germany
University of California, Davis
National Cancer Institute (NCI)

Recruiting

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) (LAYOVER)

Renal Cell Carcinoma | Oligoprogressive | Prostate Cancer | Urothelial Carcinoma

United States
Yale University

Recruiting

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Oligoprogressive | Progression

United States
University of California, Davis
National Cancer Institute (NCI)

Recruiting

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) (LIVELONG)

Oligoprogressive | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Small Bowel Cancer | Intrahepatic Cholangiocarcinoma | Gall Bladder Cancer | Extrahepatic Cholangiocarcinoma | Appendiceal Cancer | Biliary Cancer | Gastroesophageal-junction Cancer

United States
Dana-Farber Cancer Institute

Suspended

Stereotactic Magnetic Resonance Guided Radiation Therapy

Lung Cancer | Prostate Cancer | Mesothelioma | Liver Metastases | Pancreas Cancer | Renal Cancer | Brain Metastases | Spine Metastases | Borderline Resectable Pancreatic Carcinoma | Adrenal Metastases | Oligoprogressive Nodal Metastases | Metachronous Nodal Metastases | Synchronous Nodal Metastases

United States

Clinical Trials on Oligoprogressive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations